REG - Convatec Group PLC - Director/PDMR Shareholding
08/09/2025 17:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250908:nRSH4654Ya&default-theme=true
RNS Number : 4654Y Convatec Group PLC 08 September 2025
8 September 2025
Convatec Group Plc
("Convatec" or "the Company")
Director/PDMR Shareholding
This announcement provides information on Persons Discharging Managerial
Responsibility ("PDMR") dealings under the Convatec 2017 Save as You Earn
share option scheme (the "SAYE Scheme") that took place from 2022 to present.
Grant of SAYE options
On 14 July 2022, options were granted to Jonny Mason, Interim Chief Executive
Officer (then Chief Financial Officer) and PDMR over 10,346 ordinary shares of
10 pence each in the Company ("Shares") at an option price of 173.97 pence per
Share under the SAYE Scheme. The options became exercisable in the ordinary
course from 1 September 2025.
On 20 July 2023, options were granted to Karim Bitar, Chief Executive Officer
and PDMR over 10,253 Shares at an option price of 175.55 pence per Share under
the SAYE Scheme. The options will become exercisable in the ordinary course
from 1 September 2026.
Exercise of SAYE options
On 5 September 2025, Jonny Mason, exercised options over 10,346 Shares granted
on 14 July 2022 under the SAYE Scheme, at an option price of 173.97 pence per
Share.
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
Details of the person discharging managerial responsibilities / person closely
associated
Name Jonny Mason
Reason for the notification
Position/status Interim Chief Executive Officer and PDMR
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Convatec Group Plc
LEI 213800LS272L4FIDOH92
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Ordinary shares of 10p each in Convatec Group Plc
Identification code GB00BD3VFW73
Nature of the transaction Grant of options granted under the Convatec Group Plc 2017 Save As You Earn
scheme
Price(s) and volume(s)
Price(s) Volume(s)
£ 1.7397 10,346
Aggregated information
- Aggregated volume N/A
- Price
Date of the transaction 14 July 2022
Place of the transaction Outside a trading venue
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Ordinary shares of 10p each in Convatec Group Plc
Identification code GB00BD3VFW73
Nature of the transaction Exercise of options granted under the Convatec Group Plc 2017 Save As You Earn
scheme
Price(s) and volume(s)
Price(s) Volume(s)
£ 1.7397 10,346
Aggregated information
- Aggregated volume N/A - single transaction
- Price
Date of the transaction 5 September 2025
Place of the transaction Outside a trading venue
Aggregated information
- Aggregated volume
N/A
- Price
Date of the transaction
14 July 2022
Place of the transaction
Outside a trading venue
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument
Ordinary shares of 10p each in Convatec Group Plc
Identification code
GB00BD3VFW73
Nature of the transaction
Exercise of options granted under the Convatec Group Plc 2017 Save As You Earn
scheme
Price(s) and volume(s)
Price(s) Volume(s)
£ 1.7397 10,346
Aggregated information
- Aggregated volume
N/A - single transaction
- Price
Date of the transaction
5 September 2025
Place of the transaction
Outside a trading venue
Details of the person discharging managerial responsibilities / person closely
associated
Name Karim Bitar
Reason for the notification
Position/status Chief Executive Officer and PDMR
Initial notification /Amendment Initial notification
Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
Name Convatec Group Plc
LEI 213800LS272L4FIDOH92
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
Description of the financial instrument, type of instrument Ordinary shares of 10p each in Convatec Group Plc
Identification code GB00BD3VFW73
Nature of the transaction Grant of options granted under the Convatec Group Plc 2017 Save As You Earn
scheme
Price(s) and volume(s)
Price(s) Volume(s)
£ 1.7555 10,253
Aggregated information
- Aggregated volume N/A
- Price
Date of the transaction 20 July 2023
Place of the transaction Outside a trading venue
Aggregated information
- Aggregated volume
N/A
- Price
Date of the transaction
20 July 2023
Place of the transaction
Outside a trading venue
Contacts
The person responsible for making this announcement is James Kerton, Company
Secretary, Convatec Group plc: cosec@convatec.com
Media: MediaRelations@convatec.com
Investor Relations: IR@convatec.com
Convatec Group Plc's LEI code is 213800LS272L4FIDOH92
Classification: 2.2 Information disclosed under article 19 of the Market Abuse
Regulation
About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec
is a global medical products and technologies company, focused on solutions
for the management of chronic conditions, with leading positions in Advanced
Wound Care, Ostomy Care, Continence Care, and Infusion Care. With more than
10,000 colleagues, we provide our products and services in around 90
countries, united by a promise to be forever caring. Our solutions provide a
range of benefits, from infection prevention and protection of at-risk skin,
to improved patient outcomes and reduced care costs. Convatec's revenues in
2024 were over $2 billion. The company is a constituent of the FTSE 100 Index
(LSE:CTEC). To learn more please visit http://www.convatecgroup.com
(http://www.convatecgroup.com)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFLFVEAVITIIERecent news on ConvaTec
See all newsREG - Convatec Group PLC - Transaction in Own Shares
AnnouncementREG - Convatec Group PLC - Transaction in Own Shares
AnnouncementREG - Convatec Group PLC - Transaction in Own Shares
AnnouncementREG - Convatec Group PLC - Director/PDMR Shareholding
AnnouncementREG - Convatec Group PLC - Transaction in Own Shares
Announcement